{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:00:40Z","timestamp":1784815240307,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006193","name":"College of Graduate Studies, Kuwait University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02686-5","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:12:44Z","timestamp":1779433964000},"page":"1287-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin (1\u20137) exaggerates albuminuria and nephrin gene expression but does not modulate renal function-specific microRNAs expressions in kidneys of db\/db mice"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-172X","authenticated-orcid":false,"given":"Slava","family":"Malatiali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Khamisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayana","family":"Kilarkaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2686_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000324939","volume":"170","author":"E Ritz","year":"2011","unstructured":"Ritz E, Zeng XX, Rychl\u00edk I (2011) Clinical manifestation and natural history of diabetic nephropathy. Contrib Nephrol 170:19\u201327","journal-title":"Contrib Nephrol"},{"issue":"6","key":"2686_CR2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54(6):1626\u20131634","journal-title":"Diabetes"},{"issue":"2","key":"2686_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1172\/JCI119163","volume":"99","author":"ME Pagtalunan","year":"1997","unstructured":"Pagtalunan ME et al (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99(2):342\u2013348","journal-title":"J Clin Invest"},{"issue":"5","key":"2686_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0735-5","volume":"16","author":"JS Lin","year":"2016","unstructured":"Lin JS, Susztak K (2016) Podocytes: the weakest link in diabetic kidney disease? Curr Diab Rep 16(5):45","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2686_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gene.10164","volume":"35","author":"MJ Moeller","year":"2003","unstructured":"Moeller MJ et al (2003) Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 35(1):39\u201342","journal-title":"Genesis"},{"issue":"11","key":"2686_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2008020162","volume":"19","author":"J Ho","year":"2008","unstructured":"Ho J et al (2008) Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19(11):2069\u20132075","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2686_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2008030312","volume":"19","author":"S Shi","year":"2008","unstructured":"Shi S et al (2008) Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19(11):2159\u20132169","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2686_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075572","volume":"8","author":"S Shi","year":"2013","unstructured":"Shi S et al (2013) Smad2-dependent downregulation of miR-30 is required for TGF-beta-induced apoptosis in podocytes. PLoS ONE 8(9):e75572","journal-title":"PLoS ONE"},{"issue":"4","key":"2686_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestil\u00e4","year":"1998","unstructured":"Kestil\u00e4 M et al (1998) Positionally cloned gene for a novel glomerular protein\u2014nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1(4):575\u2013582","journal-title":"Mol Cell"},{"issue":"1","key":"2686_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/10.1.1","volume":"10","author":"H Putaala","year":"2001","unstructured":"Putaala H et al (2001) The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10(1):1\u20138","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2686_CR11","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1681\/ASN.2013050527","volume":"25","author":"CL Lin","year":"2014","unstructured":"Lin CL et al (2014) MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction. J Am Soc Nephrol 25(8):1698\u20131709","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2686_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10753-014-9961-7","volume":"38","author":"X Lin","year":"2015","unstructured":"Lin X et al (2015) MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy. Inflammation 38(2):546\u2013554","journal-title":"Inflammation"},{"issue":"11","key":"2686_CR13","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI81061","volume":"125","author":"J Wu","year":"2015","unstructured":"Wu J et al (2015) MicroRNA-30 family members regulate calcium\/calcineurin signaling in podocytes. J Clin Invest 125(11):4091\u20134106","journal-title":"J Clin Invest"},{"issue":"1","key":"2686_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000108758","volume":"28","author":"IF Benter","year":"2008","unstructured":"Benter IF et al (2008) Angiotensin-(1\u20137) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28(1):25\u201333","journal-title":"Am J Nephrol"},{"key":"2686_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1841046","volume":"2018","author":"AM Papinska","year":"2018","unstructured":"Papinska AM, Rodgers KE (2018) Long-term administration of angiotensin (1-7) to db\/db mice reduces oxidative stress damage in the kidneys and prevents renal dysfunction. Oxid Med Cell Longev 2018:1841046","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"2686_CR16","doi-asserted-by":"publisher","first-page":"F579","DOI":"10.1152\/ajprenal.00548.2009","volume":"298","author":"J Zhang","year":"2010","unstructured":"Zhang J et al (2010) Infusion of angiotensin-(1\u20137) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 298(3):F579\u2013F588","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2686_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1745-7254.2008.00812.x","volume":"29","author":"Y Shao","year":"2008","unstructured":"Shao Y et al (2008) Chronic angiotensin (1\u20137) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacol Sin 29(7):829\u2013837","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"2686_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.kint.2019.04.024","volume":"96","author":"P Cassis","year":"2019","unstructured":"Cassis P et al (2019) Addition of cyclic angiotensin-(1\u20137) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy. Kidney Int 96(4):906\u2013917","journal-title":"Kidney Int"},{"issue":"2","key":"2686_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240\u2013273 (Table of Contents)","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2686_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou R et al (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11(2):136\u2013140","journal-title":"Nat Immunol"},{"issue":"18","key":"2686_CR21","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1111\/bph.13225","volume":"172","author":"AM Papinska","year":"2015","unstructured":"Papinska AM et al (2015) Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db\/db mice. Br J Pharmacol 172(18):4443\u20134453","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2686_CR22","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1210\/en.2011-2031","volume":"153","author":"NM Mordwinkin","year":"2012","unstructured":"Mordwinkin NM et al (2012) Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow. Endocrinology 153(5):2189\u20132197","journal-title":"Endocrinology"},{"key":"2686_CR23","doi-asserted-by":"crossref","unstructured":"Wang WX et al (2017) Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db\/db Mice. Oxid Med Cell Longev, 2017: p. 2353729","DOI":"10.1155\/2017\/2353729"},{"issue":"2","key":"2686_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","volume":"171","author":"DW Wong","year":"2007","unstructured":"Wong DW et al (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171(2):438\u2013451","journal-title":"Am J Pathol"},{"issue":"4","key":"2686_CR25","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1046\/j.1523-1755.2000.00308.x","volume":"58","author":"P Luimula","year":"2000","unstructured":"Luimula P et al (2000) Nephrin in experimental glomerular disease. Kidney Int 58(4):1461\u20131468","journal-title":"Kidney Int"},{"issue":"1","key":"2686_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.ASN.0000037401.02391.76","volume":"14","author":"H Kawachi","year":"2003","unstructured":"Kawachi H et al (2003) Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 14(1):46\u201356","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2686_CR27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.ki.5000245","volume":"69","author":"Q Fan","year":"2006","unstructured":"Fan Q et al (2006) The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true \u2018interaction\u2019 in podocyte. Kidney Int 69(7):1207\u20131215","journal-title":"Kidney Int"},{"issue":"8","key":"2686_CR28","doi-asserted-by":"publisher","first-page":"C1174","DOI":"10.1152\/ajpcell.00450.2011","volume":"302","author":"I Sabolic","year":"2012","unstructured":"Sabolic I et al (2012) Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol 302(8):C1174\u2013C1188","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2686_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jneumeth.2008.05.003","volume":"172","author":"GM Aldridge","year":"2008","unstructured":"Aldridge GM et al (2008) The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172(2):250\u2013254","journal-title":"J Neurosci Methods"},{"issue":"14","key":"2686_CR30","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/elps.200500785","volume":"27","author":"A Dittmer","year":"2006","unstructured":"Dittmer A, Dittmer J (2006) Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis 27(14):2844\u20132845","journal-title":"Electrophoresis"},{"key":"2686_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2353729","volume":"2017","author":"WX Wang","year":"2017","unstructured":"Wang WX et al (2017) Increased oxidative damage of RNA in early-stage nephropathy in db\/db mice. Oxid Med Cell Longev 2017:2353729","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"2686_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1113\/expphysiol.2013.077610","volume":"99","author":"J Zhang","year":"2014","unstructured":"Zhang J et al (2014) A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db\/db mice by protecting podocytes. Exp Physiol 99(5):802\u2013815","journal-title":"Exp Physiol"},{"issue":"2","key":"2686_CR33","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3892\/mmr.2016.5441","volume":"14","author":"J Wan","year":"2016","unstructured":"Wan J et al (2016) GSK-3\u03b2 inhibitor attenuates urinary albumin excretion in type 2 diabetic db\/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes. Mol Med Rep 14(2):1771\u20131784","journal-title":"Mol Med Rep"},{"issue":"4","key":"2686_CR34","doi-asserted-by":"publisher","first-page":"F819","DOI":"10.1152\/ajprenal.90665.2008","volume":"296","author":"N Herbach","year":"2009","unstructured":"Herbach N et al (2009) Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. Am J Physiol Renal Physiol 296(4):F819\u2013F829","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"2686_CR35","doi-asserted-by":"publisher","first-page":"F1101","DOI":"10.1152\/ajprenal.00020.2017","volume":"312","author":"W Kriz","year":"2017","unstructured":"Kriz W et al (2017) Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. Am J Physiol Renal Physiol 312(6):F1101-f1111","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"2686_CR36","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00655.2013","volume":"306","author":"J Mori","year":"2014","unstructured":"Mori J et al (2014) Angiotensin 1\u20137 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol 306(8):F812\u2013F821","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2686_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ki.2014.274","volume":"87","author":"K Zhang","year":"2015","unstructured":"Zhang K et al (2015) Angiotensin(1\u20137) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade. Kidney Int 87(2):359\u2013369","journal-title":"Kidney Int"},{"issue":"14","key":"2686_CR38","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1073\/pnas.120055097","volume":"97","author":"FN Ziyadeh","year":"2000","unstructured":"Ziyadeh FN et al (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice. Proc Natl Acad Sci USA 97(14):8015\u20138020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2686_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1053\/meta.2001.28074","volume":"50","author":"MP Cohen","year":"2001","unstructured":"Cohen MP, Lautenslager GT, Shearman CW (2001) Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d\/db mice. Metabolism 50(12):1435\u20131440","journal-title":"Metabolism"},{"key":"2686_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137230","author":"JJ Yoon","year":"2021","unstructured":"Yoon JJ et al (2021) Protective effects of ethanolic extract from rhizome of Polygoni avicularis against renal fibrosis and inflammation in a diabetic nephropathy model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22137230","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2686_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.33549\/physiolres.934784","volume":"71","author":"M Maekawa","year":"2022","unstructured":"Maekawa M et al (2022) Pathophysiological analysis of uninephrectomized db\/db mice as a model of severe diabetic kidney disease. Physiol Res 71(2):209\u2013217","journal-title":"Physiol Res"},{"key":"2686_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pr9040694","author":"H Hsu","year":"2021","unstructured":"Hsu H et al (2021) Curcumin reinforces MiR-29a expression, reducing mesangial fibrosis in a model of diabetic fibrotic kidney via modulation of CB1R signaling. Processes. https:\/\/doi.org\/10.3390\/pr9040694","journal-title":"Processes"},{"key":"2686_CR43","unstructured":"Jing M et al (2020) Expression and role of microRNA-155 in db\/db mice. Chin J Nephrol 463-470."},{"key":"2686_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/920134","volume":"2014","author":"H Wu","year":"2014","unstructured":"Wu H et al (2014) The role of microRNAs in diabetic nephropathy. J Diabetes Res 2014:920134","journal-title":"J Diabetes Res"},{"issue":"11","key":"2686_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.335","volume":"7","author":"WT Liu","year":"2016","unstructured":"Liu WT et al (2016) Metadherin facilitates podocyte apoptosis in diabetic nephropathy. Cell Death Dis 7(11):e2477","journal-title":"Cell Death Dis"},{"issue":"2","key":"2686_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/acel.12563","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y et al (2017) MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db\/db mice. Aging Cell 16(2):387\u2013400","journal-title":"Aging Cell"},{"issue":"3","key":"2686_CR47","first-page":"1338","volume":"24","author":"BH Gao","year":"2020","unstructured":"Gao BH et al (2020) MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Eur Rev Med Pharmacol Sci 24(3):1338\u20131349","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2686_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24020264","author":"CW Tung","year":"2019","unstructured":"Tung CW et al (2019) MicroRNA-29a attenuates diabetic glomerular injury through modulating cannabinoid receptor 1 signaling. Molecules. https:\/\/doi.org\/10.3390\/molecules24020264","journal-title":"Molecules"},{"issue":"9","key":"2686_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/labinvest.3780332","volume":"81","author":"P Aaltonen","year":"2001","unstructured":"Aaltonen P et al (2001) Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81(9):1185\u20131190","journal-title":"Lab Invest"},{"issue":"4","key":"2686_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ki.2008.559","volume":"75","author":"A Ijaz","year":"2009","unstructured":"Ijaz A et al (2009) Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int 75(4):381\u2013388","journal-title":"Kidney Int"},{"key":"2686_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/769416","volume":"2013","author":"E Sohn","year":"2013","unstructured":"Sohn E et al (2013) The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db\/db mice. Evid Based Complement Alternat Med 2013:769416","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"2686_CR52","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1248\/bpb.b12-00634","volume":"36","author":"G Zhou","year":"2013","unstructured":"Zhou G et al (2013) Probucol inhibited Nox2 expression and attenuated podocyte injury in type 2 diabetic nephropathy of db\/db mice. Biol Pharm Bull 36(12):1883\u20131890","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"2686_CR53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4239\/wjd.v11.i12.596","volume":"11","author":"VV Klimontov","year":"2020","unstructured":"Klimontov VV et al (2020) Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db\/db diabetic mice. World J Diabetes 11(12):596\u2013610","journal-title":"World J Diabetes"},{"key":"2686_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2021.104403","volume-title":"Betacyanins attenuates diabetic nephropathy in mice by inhibiting fibrosis and oxidative stress via the improvement of Nrf2 signaling","author":"G Chenxu","year":"2021","unstructured":"Chenxu G et al (2021) Betacyanins attenuates diabetic nephropathy in mice by inhibiting fibrosis and oxidative stress via the improvement of Nrf2 signaling. Elsevier, Amsterdam"},{"issue":"11","key":"2686_CR55","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1681\/ASN.2006010064","volume":"17","author":"SH Sung","year":"2006","unstructured":"Sung SH et al (2006) Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17(11):3093\u20133104","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2686_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102605","volume":"298","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Long noncoding RNA SNHG5 promotes podocyte injury via the microRNA-26a-5p\/TRPC6 pathway in diabetic nephropathy. J Biol Chem 298(12):102605","journal-title":"J Biol Chem"},{"key":"2686_CR57","doi-asserted-by":"crossref","unstructured":"Cheong Y et al (2020) A dipeptidyl peptidase inhibitor, evogliptin, directly prevents nephrin loss and podocyte damage via post-transcriptional regulation. Diabetes Updates 6:1-11","DOI":"10.15761\/DU.1000139"},{"key":"2686_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.781806","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F et al (2022) Effects of Shenkang Pills on early-stage diabetic nephropathy in db\/db mice via inhibiting AURKB\/RacGAP1\/RhoA signaling pathway. Front Pharmacol 13:781806","journal-title":"Front Pharmacol"},{"issue":"15","key":"2686_CR59","doi-asserted-by":"publisher","first-page":"12959","DOI":"10.1074\/jbc.M110.204024","volume":"286","author":"I Quack","year":"2011","unstructured":"Quack I et al (2011) PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Biol Chem 286(15):12959\u201312970","journal-title":"J Biol Chem"},{"issue":"8","key":"2686_CR60","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/sj.ki.5001830","volume":"70","author":"J Menne","year":"2006","unstructured":"Menne J et al (2006) Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int 70(8):1456\u20131462","journal-title":"Kidney Int"},{"issue":"9","key":"2686_CR61","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1096\/fj.201601265R","volume":"31","author":"V Dumont","year":"2017","unstructured":"Dumont V et al (2017) PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease. FASEB J 31(9):3978\u20133990","journal-title":"FASEB J"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02686-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02686-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02686-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:02:26Z","timestamp":1784811746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02686-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2686"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02686-5","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}